Kratom Supplement Marketers Dispute FDA Warning, Ask For Review

In addition to a review of the advisory announced by FDA Commissioner Gottlieb, a trade group petitions the agency for a meeting to allow stakeholders "to correct misstatements and factual errors on the science regarding the safety and addiction potential of kratom."